From: Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
RM | DCIS | IDC | DCIS & IDC | ||||||
---|---|---|---|---|---|---|---|---|---|
ER | PR | HER2 | |||||||
Pos | Neg | Pos | Neg | Pos | Neg | ||||
Weak | 29 (73) | 7 (23) | 20 (31) | 21 (26) | 8 (57) | 16 (23) | 12 (48) | 7 (29) | 20 (30) |
Strong | 11 (27) | 24 (77) | 45 (65) | 60 (74) | 6 (43) | 54 (77) | 13 (52) | 17 (71) | 47 (70) |